IFFIm receives eighth consecutive A+ rating from UK FCDO

IFFIm receives eighth consecutive A+ rating from UK FCDO

20 November 2026

The UK Foreign, Commonwealth & Development Office's 2025 Annual Review confirms an A+ rating for IFFIm for the eighth year running.

The UK Foreign, Commonwealth & Development Office's 2025 Annual Review confirms an A+ rating for IFFIm for the eighth year running.

Consistency is the strongest evidence that a financing mechanism works. IFFIm is delighted to be a model of consistency, with its eighth consecutive A+ rating from the UK Foreign, Commonwealth & Development Office's (FCDO) 2025 Annual Review.

As a global financing platform, IFFIm allows Gavi, the Vaccine Alliance to frontload resources or draw down funds over time, enabling Gavi to invest in immunisation programmes when funds will have the greatest impact. In parallel, IFFIm’s steady funding stream strengthens Gavi’s ability to shape vaccine markets while also providing it with access to fast, reliable surge financing in case of emergencies. With the World Bank serving as the facility's treasury Manager since inception, IFFIm has proven to be an effective model for donors looking to accelerate the life-saving returns on their contributions.

Why the rating matters

The UK is IFFIm's founding and largest sovereign donor, and it assesses IFFIm every year as an efficient and effective financial instrument. An eighth consecutive A+ rating shows that the IFFIm’s model is consistent and resilient, and signals to donors worldwide that the UK believes IFFIm performs highly in supporting global immunisation outcomes at scale.

That consistency builds trust. By turning long-term donor pledges into funding that is available immediately, IFFIm helps Gavi to plan, commit and negotiate with confidence; not just as a financial tool, but as a trusted partner. As global health challenges become more complex, it is more vital than ever for Gavi to be able to deliver at speed, and to ensure strategic impact every time, without fail.

Looking ahead

Twenty years after its founding, IFFIm embarks on Gavi’s new five-year strategy – Phase 6 – to materialise its vision: Leaving no one behind with immunisation. That means saving lives and protecting people’s health by increasing the equitable and sustainable use of vaccines worldwide. Donors play a crucial role in making this happen.

As well as assessing recent performance, the FCDO review also looks ahead. Its recommendations equip IFFIm with valuable tools to deepen and broaden its relationships with the donors that will help make the vision of Gavi 6.0 a reality.

“An eighth A+ rating in FCDO’s annual review, as we celebrate IFFIm’s 20th anniversary, is a significant recognition of the strength and enduring relevance of IFFIm’s innovative financing model,” said Georgina Baker, Chair of the IFFIm Board. “Over the past two decades, IFFIm has demonstrated how bringing financing forward can help deliver timely and meaningful impact for global immunisation. As we look ahead, this recognition reinforces the important role innovative finance can continue to play in responding to global health needs.”

Rachel Turner, IFFIm Board Member, added: “Having been there at the beginning of IFFIm, it is remarkable to look back and see how an ambitious idea has evolved into a proven approach that has stood the test of time. Twenty years later, receiving an eighth A+ rating in FCDO’s annual review is an important milestone and a moment to be proud of. It reflects what IFFIm has achieved over two decades and, importantly, the dedication and collaboration of everyone who has played a part in its success along the way.”

Share this article